Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Bettacchi A, Mulattieri S, Picardi P, Tassetti A, Scortechini AR, Fioritoni G, Leoni P. Pulini S, et al. Among authors: alterini r. Eur J Haematol. 2009 Mar;82(3):184-93. doi: 10.1111/j.1600-0609.2008.01197.x. Eur J Haematol. 2009. PMID: 19215609 Clinical Trial.
Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.
Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Tassetti A, Scortechini AR, Offidani M, Mulattieri S, Stronati A, Brandozzi G, Giacchetti A, Mozzicafreddo G, Ricotti G, Filosa G, Bettacchi A, Simonacci M, Novelli N, Leoni P. Pulini S, et al. Among authors: alterini r. Haematologica. 2007 May;92(5):686-9. doi: 10.3324/haematol.10879. Haematologica. 2007. PMID: 17488695 Free article. Clinical Trial.
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, Martelli M, Alaibac M, Borroni G, Chimenti S, Alterini R, Alinari L, Fierro MT, Cappello N, Pileri A, Soligo D, Paulli M, Pileri S, Santucci M, Bernengo MG; Italian Study Group for Cutaneous Lymphomas. Zinzani PL, et al. Among authors: alterini r. J Clin Oncol. 2006 Mar 20;24(9):1376-82. doi: 10.1200/JCO.2005.03.6285. Epub 2006 Feb 21. J Clin Oncol. 2006. PMID: 16492713
Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides.
Rupoli S, Canafoglia L, Goteri G, Leoni P, Brandozzi G, Federici I, Micucci G, Giantomassi F, Mozzicafreddo G, Alterini R, Filosa G, Ricotti G, Simonacci M, Scortechini AR, Zizzi A, Pimpinelli N. Rupoli S, et al. Among authors: alterini r. Eur J Dermatol. 2016 Jan-Feb;26(1):13-20. doi: 10.1684/ejd.2015.2672. Eur J Dermatol. 2016. PMID: 26678311 Clinical Trial.
Combination treatment in CTCL: the current role of bexarotene.
Delfino C, Grandi V, Pileri A, Rupoli S, Quaglino P, Alterini R, Goteri G, Canafoglia L, Pimpinelli N. Delfino C, et al. Among authors: alterini r. G Ital Dermatol Venereol. 2012 Dec;147(6):573-80. G Ital Dermatol Venereol. 2012. PMID: 23149703
43 results